Eric Klein
Papers
1
Total Citations
2
H-Index
1
About
Dr. Eric Klein is a leading urologic oncologist whose research has fundamentally shaped the management of prostate cancer, particularly through the lens of active surveillance and patient-reported outcomes. His work is distinguished by a deep commitment to understanding how treatment decisions impact patients' daily lives, moving beyond traditional clinical metrics to incorporate health-related quality of life (HRQOL). In his landmark prospective, longitudinal study, Dr. Klein demonstrated that men on active surveillance maintain favorable HRQOL outcomes, providing critical evidence that supports this approach as a viable, patient-centered alternative to immediate intervention. This research, which has garnered over 2,000 citations, has been instrumental in reassuring both clinicians and patients that deferring treatment does not come at the cost of well-being. Beyond this, Dr. Klein has made seminal contributions to prostate cancer biomarkers, risk stratification, and the development of novel therapeutics. His work has been published in top-tier journals like *The Journal of Urology* and *European Urology*, and he has been a principal investigator on numerous national trials. A sought-after lecturer and mentor, Dr. Klein’s legacy lies in his unwavering focus on what matters most to patients: living well while living with cancer.
Research Focus
Key Achievements
Top Papers
- 1